The Id protein has been used for immunotherapy both in vitro and in vivo in MM and has demonstrated a successful response in follicular lymphoma and a unique expression of Id on the malignant B cell clone [15, 16]. This evidence concerns the gene ID1 and Miyoshi myopathy.